Field Trip Health Ltd. (FTRP)
$0.8421
+0.01 (+1.07%)
Rating:
Recommendation:
-
| Symbol | FTRP |
|---|---|
| Price | $0.8421 |
| Beta | 0.000 |
| Volume Avg. | - |
| Market Cap | 9.806M |
| Shares () | - |
| 52 Week Range | |
| 1y Target Est | - |
| DCF Unlevered | FTRP DCF -> | |
|---|---|---|
| DCF Levered | FTRP LDCF -> | |
| ROE | -32.89% | Strong Sell |
| ROA | -22.46% | Sell |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | -1.22 | Sell |
| P/B | 0.25 | Neutral |
Latest FTRP news
About
Download (Excel)Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.